Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01430767 · ClinicalTrials.gov registry record

Measuring Adherence to Medication for Depression and Attention-deficit Hyperactivity Disorder

A clinical trial of Major Depressive Disorder and Attention Deficit Hyperactivity Disorder (ADHD), sponsored by Wake Forest University Health Sciences.

Completed
Registry status
33
Enrollment target
1
Study location

NCT01430767 is a study of Major Depressive Disorder and Attention Deficit Hyperactivity Disorder (ADHD) that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 33 participants, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01430767, a study of Major Depressive Disorder and Attention Deficit Hyperactivity Disorder (ADHD), has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
33 participants
Enrollment target
1
Study location

Study Summary

Poor adherence is a common reason for treatment failure in many fields of medicine, and likely affects common psychiatric treatments as well. Members of the present study team have used Medication Event Monitoring System (MEMS®) caps effectively to objectively monitor adherence in skin disease, and have shown that they provide a much more accurate measure of adherence behavior than self-reports, pill counts, or serum drug concentrations. The present study will use MEMS® caps to measure adherence in 10 patients with depression and 10 patients with attention-deficit hyperactivity disorder (ADHD) from a student clinic population. The aims will be to show the usefulness of MEMS® caps in measuring adherence to psychiatric treatment, and gather data on typical adherence rates for depression and ADHD patients on typical treatment regimens. The data obtained will be used to inform future studies that use an intervention to improve adherence behavior and ultimately disease outcomes.

Conditions Studied

Major Depressive Disorder Attention Deficit Hyperactivity Disorder (ADHD)

Study Locations (1)

North Carolina

  • Wake Forest University Health Sciences - Winston-Salem

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2011-09
Est. Completion 2014-12

Sponsor

Wake Forest University Health Sciences

1,140 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01430767

The ClinicalTrials.gov registry entry for NCT01430767 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (91% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Major Depressive Disorder appearing as the primary indexed condition, and to 0 interventions.

NCT01430767 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT01430767 about?

NCT01430767 is a clinical study titled "Measuring Adherence to Medication for Depression and Attention-deficit Hyperactivity Disorder". Poor adherence is a common reason for treatment failure in many fields of medicine, and likely affects common psychiatric treatments as well. Members of the present study team have used Medication Event Monitoring System (MEMS®) caps effectively to objectively monitor adherence in skin disease, and ...

What is the current status of trial NCT01430767?

This trial is currently completed. The enrollment target is 33 participants. The study started on 2011-09. Estimated completion is 2014-12.

What conditions does trial NCT01430767 study?

This clinical trial studies the following conditions: Major Depressive Disorder, Attention Deficit Hyperactivity Disorder (ADHD).

Who is sponsoring clinical trial NCT01430767?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01430767 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Major Depressive Disorder

All registered trials for this condition

Attention Deficit Hyperactivity Disorder (ADHD)

All registered trials for this condition

North Carolina

All trials with a study site in North Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.